186 related articles for article (PubMed ID: 21673581)
1. Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.
Haga SB; Kawamoto K; Agans R; Ginsburg GS
Genet Med; 2011 Oct; 13(10):887-90. PubMed ID: 21673581
[TBL] [Abstract][Full Text] [Related]
2. Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
Genet Med; 2011 Aug; 13(8):723-8. PubMed ID: 21633294
[TBL] [Abstract][Full Text] [Related]
3. Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs.
McDermott JH; Sharma V; Newman WG; Wilson P; Payne K; Wright S
Br J Clin Pharmacol; 2024 Jul; 90(7):1699-1710. PubMed ID: 38616172
[TBL] [Abstract][Full Text] [Related]
4. Survey of US public attitudes toward pharmacogenetic testing.
Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
Pharmacogenomics J; 2012 Jun; 12(3):197-204. PubMed ID: 21321582
[TBL] [Abstract][Full Text] [Related]
5. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
[No Abstract] [Full Text] [Related]
6. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
[TBL] [Abstract][Full Text] [Related]
7. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
[TBL] [Abstract][Full Text] [Related]
8. Public preferences for electronic health data storage, access, and sharing - evidence from a pan-European survey.
Patil S; Lu H; Saunders CL; Potoglou D; Robinson N
J Am Med Inform Assoc; 2016 Nov; 23(6):1096-1106. PubMed ID: 27107445
[TBL] [Abstract][Full Text] [Related]
9. Positive perception of pharmacogenetic testing for psychotropic medications.
Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
[TBL] [Abstract][Full Text] [Related]
12. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
14. Patients' and physicians' perspectives on pharmacogenetic testing.
Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
[TBL] [Abstract][Full Text] [Related]
15. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery.
Powell G; Holmes EA; Plumpton CO; Ring A; Baker GA; Jacoby A; Pirmohamed M; Marson AG; Hughes DA
Br J Clin Pharmacol; 2015 Nov; 80(5):1149-59. PubMed ID: 26138622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
[TBL] [Abstract][Full Text] [Related]
18. Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Luzum JA; Petry N; Taylor AK; Van Driest SL; Dunnenberger HM; Cavallari LH
Clin Pharmacol Ther; 2021 Sep; 110(3):649-661. PubMed ID: 34101169
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of health care professionals toward pharmacogenetic testing.
Zgheib NK; Arawi T; Mahfouz RA; Sabra R
Mol Diagn Ther; 2011 Apr; 15(2):115-22. PubMed ID: 21623646
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
Albitar L; Alchamat GA
BMC Health Serv Res; 2021 Oct; 21(1):1031. PubMed ID: 34592972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
